CDH2 and neoplasm: At the molecular level, the epithelial biomarker CDH1 is downregulated, and the mesenchymal biomarkers N-cadherin (CDH2) and fibronectin (FN1) are upregulated in tumor buds, thus suggesting that tumor buds have mesenchymal characteristics.